Virtual Medicinal Product (VMP) - Levothyroxine sodium 125micrograms/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Levothyroxine sodium 125micrograms/5ml oral suspension | Start Date 01-12-2004 | End Date |
| Previous Name | Previous Name Levothyroxine sodium 125micrograms/5ml oral suspension | Start Date 18-11-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- H03AA01
- BNF Codes
-
- BNF code 06020100
| Code | Start Date | End Date |
|---|---|---|
| 8584711000001103 | 18-11-2004 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Levothyroxine sodium anhydrous | Based on Ingredient Substance | 25 microgram | 1 ml |
Name
Levothyroxine sodium anhydrous
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
1
Parent Products
-
VTMLevothyroxine
-
VMP(Current) Levothyroxine sodium 125micrograms/5...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |